Cargando…

Combination of C21 and ARBs with rhACE2 as a therapeutic protocol: A new promising approach for treating ARDS in patients with coronavirus infection

Background: Coronavirus disease 2019 (COVID-19) is caused by a new severe acute respiratory syndrome Coronavirus. COVID-19 patients are at risk for acute respiratory distress syndrome and death from respiratory failure. Methods: In this study the complete genome of the SARS-CoV-2 reference sequence,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Soheili, Marzieh, Haji-allahverdipoor, Kaveh, Khadem-erfan, Mohamad Bagher, Baban, Babak, Nikkhoo, Bahram, Eliasi, Anwar, Nasseri, Sherko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Iran University of Medical Sciences 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722962/ https://www.ncbi.nlm.nih.gov/pubmed/33316002 http://dx.doi.org/10.34171/mjiri.34.120

Ejemplares similares

Insights Into The Effects of Amino Acid Substitutions on The Stability of Reteplase Structure: A Molecular Dynamics Simulation Study
por: Haji-Allahverdipoor, Kaveh, et al.
Publicado: (2023)

RhACE2 – playing an important role in inhibiting apoptosis induced by Ang II in HUVECs
por: Zhang, Hongli, et al.
Publicado: (2019)

rhACE2 Therapy Modifies Bleomycin-Induced Pulmonary Hypertension via Rescue of Vascular Remodeling
por: Rathinasabapathy, Anandharajan, et al.
Publicado: (2018)

Myocardial fibrosis reversion via rhACE2-electrospun fibrous patch for ventricular remodeling prevention
por: Qiu, Zeping, et al.
Publicado: (2021)

Association and pharmacological synergism of the triple drug therapy baricitinib/remdesivir/rhACE2 for the management of COVID-19 infection
por: Vitiello, Antonio, et al.
Publicado: (2021)

Human papilloma virus: A review study of epidemiology, carcinogenesis, diagnostic methods, and treatment of all HPV-related cancers
por: Soheili, Maryam, et al.
Publicado: (2021)

Treatment Options Available for COVID-19 and an Analysis on Possible Role of Combination of rhACE2, Angiotensin (1-7) and Angiotensin (1-9) as Effective Therapeutic Measure
por: Muslim, Shahnawaz, et al.
Publicado: (2020)

ACE2 localizes to the respiratory cilia and is not increased by ACE inhibitors or ARBs
por: Lee, Ivan T., et al.
Publicado: (2020)

The effects of supplemented sericin on in vitro maturation and preimplantation development of mouse embryos: An experimental study
por: Banafshi, Omid, et al.
Publicado: (2021)

The prevalence of Human Papilloma Virus (HPV) infection in the oligospermic and azoospermic men
por: Nasseri, Sherko, et al.
Publicado: (2015)

Controversy regarding ACE inhibitors / ARBs in COVID-19
por: Soria Arcos, Federico, et al.
Publicado: (2020)

ASSOCIATION BETWEEN IN-HOSPITAL MORTALITY AND ACE/ARB INHIBITOR USAGE
por: Ruge, Max, et al.
Publicado: (2022)

COVID-19-related deaths not increased with ACE inhibitor or ARB use
Publicado: (2020)

The effect of ACE inhibitors and ARBs on outcomes in hospitalized patients with COVID-19
por: Najafi, Narges, et al.
Publicado: (2022)

What Evidence Supports Guidelines for Use of ACE Inhibitors and ARBs in Diabetes?
por: Curtiss, Frederic R.
Publicado: (2006)

Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients
por: Rossi, Gian Paolo, et al.
Publicado: (2020)

The concern about ACE/ARB and COVID-19: Time to hold your horses!
por: Pergolizzi, Joseph V., et al.
Publicado: (2020)

ACE-inhibitor/angiotensin receptor blockers (ACE-I/ARBs) therapy in COVID-19 infected dialysis patients
por: Daoud, Ahmed, et al.
Publicado: (2021)

ACE-I/ARB Therapy prior to Contrast Exposure: What Should the Clinician Do?
por: Kalyesubula, Robert, et al.
Publicado: (2014)

The influence of ACE inhibitors and ARBs on hospital length of stay and survival in people with COVID-19
por: Braude, Philip, et al.
Publicado: (2020)

SARS-CoV-2 downregulation of ACE2 and pleiotropic effects of ACEIs/ARBs
por: Ciulla, Michele M.
Publicado: (2020)

Hospital mortality in COVID-19 patients in Belgium treated with statins, ACE inhibitors and/or ARBs
por: Byttebier, Geert, et al.
Publicado: (2021)

COVID-19: The Influence of ACE Genotype and ACE-I and ARBs on the Course of SARS-CoV-2 Infection in Elderly Patients
por: Sieńko, Jerzy, et al.
Publicado: (2020)

Antihypertensive medication uses and serum ACE2 levels: ACEIs/ARBs treatment does not raise serum levels of ACE2
por: Emilsson, Valur, et al.
Publicado: (2020)

Continue ACE inhibitors / ARB’S till further evidence in coronavirus disease 2019 (COVID-19)
por: Bansal, Sandeep, et al.
Publicado: (2020)

Treatment with ACE inhibitors or ARBs and risk of severe/lethal COVID-19: a meta-analysis
por: Flacco, Maria Elena, et al.
Publicado: (2020)

NO EXCESS MORTALITY ASSOCIATED WITH CONCOMITANT ACE INHIBITOR OR ARB USE IN HOSPITALIZED PATIENTS WITH COVID-19
por: Annie, Frank H., et al.
Publicado: (2021)

ACE Inhibitor and ARB Utilization and Expenditures in the Medicaid Fee-For-Service Program from 1991 to 2008
por: Bian, Boyang, et al.
Publicado: (2010)

ACE2 and COVID-19 and the resulting ARDS
por: Zhang, Xiaoqing, et al.
Publicado: (2020)

SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy
por: Chung, Mina K., et al.
Publicado: (2020)

Characterization of Escherichia coli isolated from urinary tract infection and association between virulence expression and antimicrobial susceptibility
por: Derakhshan, Safoura, et al.
Publicado: (2022)

Recombinant human ACE2: acing out angiotensin II in ARDS therapy
por: Zhang, Haibo, et al.
Publicado: (2017)

Safety of ACE-I and ARB medications in COVID-19: A retrospective cohort study of inpatients and outpatients in California
por: Rubin, Samuel J. S., et al.
Publicado: (2021)

In silico prediction of ARB resistance: A first step in creating personalized ARB therapy
por: Anderson, Shane D., et al.
Publicado: (2020)

Evaluation of the Effect of Vitamin E on Reproductive Parameters in Morphine-Treated Male Mice
por: Arjmand, Katayoon, et al.
Publicado: (2023)

Cardiovascular risk reduction by reversing endothelial dysfunction:ARBs, ACE inhibitors, or both? Expectations from The ONTARGET Trial Programme
por: Ruilope, Luis Miguel, et al.
Publicado: (2007)

Aliskiren: Just a New Drug for Few Selected Patients or an Innovative Molecule Predestinated to Replace Arbs and Ace-Inhibitors?
por: Novo, Salvatore, et al.
Publicado: (2009)

149 Association of ACE-I and ARB Prescriptions With Mortality in Patients Admitted to the Hospital With COVID-19 in New York City
por: Barrett, B., et al.
Publicado: (2020)

Impact of Beta-blocker, ACE Inhibitor, and ARB therapy on thoracic aorta wall shear stress in bicuspid aortic valve patients
por: McGee, Katherine, et al.
Publicado: (2016)

ACEI/ARB therapy in COVID-19: the double-edged sword of ACE2 and SARS-CoV-2 viral docking
por: Onweni, Chidinma L., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3cvl78on62g1g4dfm724k50vlt